T he paper by Lipworth and colleagues 1 represents the seventh publication since 2001 to report an increased rate of death attributed to suicide among women with cosmetic breast implants. Consistent with the previous studies, the investigators found a 3-fold increase in deaths attributed to suicide as compared with the expected number of deaths by suicide among Swedish women of the same age cohort. The authors also found a 3 times greater rate of deaths attributed to alcohol or substance abuse, as well as additional deaths attributed to accidents or injuries that could have been associated with alcohol or drug use. These findings, taken together, suggest the presence of premorbid psychopathology among at least a sizable minority of women who receive cosmetic breast implants. 1 Like the previous papers in this area, the present investigation was a large epidemiologic study designed primarily to investigate all-cause mortality attributed to cosmetic breast implants. The association between breast implants and suicide was, at least in the early reports, an unanticipated finding. As a result, studies in this area provided few clues as to the nature of the relationship between breast implants and suicide. At least 3 possible explanations of the relationship have some empirical support or intuitive appeal. 2-4 They include women's motivations and expectations for surgery, the role of certain personality characteristics and psychopathology, as well as the impact of postoperative complications. Of these, the role of preoperative psychopathology appears, at least presently, to be the most reasonable explanation for the relationship.
T he paper by Lipworth and colleagues 1 represents the seventh publication since 2001 to report an increased rate of death attributed to suicide among women with cosmetic breast implants. Consistent with the previous studies, the investigators found a 3-fold increase in deaths attributed to suicide as compared with the expected number of deaths by suicide among Swedish women of the same age cohort. The authors also found a 3 times greater rate of deaths attributed to alcohol or substance abuse, as well as additional deaths attributed to accidents or injuries that could have been associated with alcohol or drug use. These findings, taken together, suggest the presence of premorbid psychopathology among at least a sizable minority of women who receive cosmetic breast implants. 1 Like the previous papers in this area, the present investigation was a large epidemiologic study designed primarily to investigate all-cause mortality attributed to cosmetic breast implants. The association between breast implants and suicide was, at least in the early reports, an unanticipated finding. As a result, studies in this area provided few clues as to the nature of the relationship between breast implants and suicide. At least 3 possible explanations of the relationship have some empirical support or intuitive appeal. [2] [3] [4] They include women's motivations and expectations for surgery, the role of certain personality characteristics and psychopathology, as well as the impact of postoperative complications. Of these, the role of preoperative psychopathology appears, at least presently, to be the most reasonable explanation for the relationship.
A number of studies have suggested that breast augmentation candidates differ from other women on a variety of unique personality characteristics, including more frequent use of psychiatric treatment, alcohol, and tobacco and having a higher divorce rate. Several of these traits are, in and of themselves, associated with an increased risk of suicide. In their study of 2761 Danish women with breast implants, Jacobsen and colleagues 5 not only found a 3 times greater number of deaths attributed to suicide but also found a significantly higher rate of previous psychiatric hospitalizations among women with breast implants (8%) as compared with women who underwent breast reduction (4.7%) or other cosmetic procedures (4.7%). While the study by Lipworth et al 1 did not provide any additional information on the psychiatric hospitalization history of women with breast implants, the increased number of deaths attributed either directly to substance abuse or to accidents related to substance abuse further implicates the role of preexisting psychopathology in the suicides.
Beyond the association with substance abuse, little is known about what forms of psychopathology may be contributing to the suicides. Undoubtedly, major depression has great intuitive appeal. Body dysmorphic disorder (BDD) also must be considered. Defined as a preoccupation with a slight or imagined defect in appearance that leads to significant disruption in daily functioning, BDD has been found in 5%-15% of cosmetic surgery patients. 6 Retrospective studies of persons with BDD who have undergone cosmetic treatments have found that greater than 90% experienced either no change or a worsening in their BDD symptoms following these treatments. 7 Over 50% of BDD patients reported thinking about suicide in the past year and more than 2% reported a suicide attempt within the past year. 8 These rates are approximately 10 -25 and 2-12 times higher, respectively, than those in the general population. It is quite possible that some of the suicides seen in women with breast implants could be associated with BDD.
While we wait for additional studies on the relationship between cosmetic breast implants and suicide, the findings of the present study, as well as the other investigations in this area, should be used to guide the clinical management of cosmetic breast augmentation patients. [1] [2] [3] [4] As is typically done in other initial medical consultations, the plastic surgeon should assess a breast augmentation candidate's mental health status and history as a screen for the presence of psychopathology. As described in detail elsewhere, 4,9 this should include an assessment of the patient's presentation and demeanor but also inquiry regarding symptoms of mood or body image disorders, such as BDD. Patients suspected of having one of these disorders or any major psychiatric illness should undergo a mental health consultation prior to surgery.
The surgeon also should ask about a history of psychiatric treatment, including outpatient psychotherapy, pharma-cotherapy, and, in particular, psychiatric hospitalizations. In cases where the patient is currently in mental health treatment, the surgeon should contact the mental health professional to confirm that the patient is psychiatrically stable and appropriate for surgery at this time. The failure to communicate with the treating mental health professional has been used as part of a number of malpractice cases directed at plastic surgeons. In cases where the patient reports a history of psychiatric treatment but is not engaged in treatment at present, a preoperative psychiatric consultation is suggested.
Admittedly, these clinical recommendations are debatable, if not controversial. However, until we know more about the relationship between breast implants and suicide, this conservative approach is recommended with both the patient's and surgeon's well-being in mind.
